Innovating Works

CIBER ENFERMEDADES NEURODEGENERATIVAS

Activa
PurinesDX: Interdisciplinary training network on the purinergic P2X7 receptor to control neuroinflammation and... CIBER ENFERMEDADES NEURODEGENERATIVAS participó en un H2020: H2020-MSCA-ITN-2017 Brain disorders affect ~179 million people and their families in Europe alone, with an annual cost to the taxpayer estimated at €800 billion...
2017-08-17 - 2021-08-31 | Financiado
BBDiag: Blood Biomarker based Diagnostic Tools for Early Stage Alzheimer s Disease CIBER ENFERMEDADES NEURODEGENERATIVAS participó en un H2020: H2020-MSCA-ITN-2016 Alzheimer’s disease (AD) affects more than 7 million people in Europe and this figure is expected to double every 20 years. Despite intensiv...
2016-09-12 - 2021-12-31 | Financiado
NAD: NANOPARTICLES FOR THERAPY AND DIAGNOSIS OF ALZHEIMER DISEASE CIBER ENFERMEDADES NEURODEGENERATIVAS participó en un FP7: The search for effective therapies and early detection strategies for Alzheimer’s Disease (AD), the major cause of dementia in Europe, is im...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.